4DMedical is trading 9.05% down now at A$4.22, based on the latest provided price context for the August 7, 2026 session; no new company-specific announcement clearly explains the decline.

  • No new company-specific announcement dated August 7–10 clearly explains the decline.
  • The latest listed update was an August 3 partnership with RevealDx.
  • Earlier fiscal-year revenue news supported a prior rally; the sharp reversal remains an unclear catalyst rather than a confirmed fundamental reaction.